Home  
  Glamour
Shots
 
  FAQ  
  Contacts  
  Press
Kit
 
  Authorized Bio  
  Trailer  
  Flash
Trailer
 
  Screenings  
  Downloads  
  Newsletter  
  Official PayPal SealOfficial PayPal Seal  

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting Chimerix.

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting Chimerix, Inc tadalis deutschland ., a pharmaceutical company developing orally-obtainable antiviral therapeutics, will present promising clinical data for CMX001 in a late-breaker poster session at the Infectious Illnesses Culture of America 48th Annual Meeting. Adenovirus infections among immunocompromised patients can be potentially fatal, with no approved treatments obtainable. Painter, M.D., Chief Medical Officer of Chimerix. CMX001 is certainly a broad-spectrum antiviral agent with demonstrated activity against multiple double-stranded DNA viruses, primarily being produced by Chimerix for the treating viral infections in immunocompromised transplant sufferers.92-66 years) received at least a month of treatment with CMX001 for adenovirus disease under investigator-kept Emergency Investigational Brand-new Drug applications .98 log10.

  Member Area  
  LLX Internet Services  
  Cornerstone 28  
  The Valet  
  Underground Railroad  
  Event Gallery  
  Sponsors  
  Endorsements  
  Moon in Leo Prod.  
  Diamond And Sphinx  
  Chris Cory  
  Site Update Log